SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.53+4.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (3685)5/5/2001 12:42:34 PM
From: Biomaven  Read Replies (1) of 52153
 
smh,

Just recovering from a biotech OD - visited a bunch of companies over two days together with some other biofreaks. Thanks everyone for taking care of the thread while I was gone.

On ASCO, one comment I heard was that this was overall a relatively slow news year. Glivec will obviously (and rightly so) be front and center.

I hold a number of cancer stocks, none in large quantities. The three that I think might get most hype out of ASCO are IMCL, IMGN and TELK. CELG and MOGN are also presenting and might also pop if they break any news.

Now back to recuperation. <g>

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News